US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist

1.345
-0.075-5.28%

Trading Dec 19 13:24 ET

185.06MMarket Cap-3.84P/E (TTM)

Compass Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-86.61%-11.05M

-6.34%-10.75M

-13.57%-13.89M

-19.03%-40.62M

-16.10%-12.35M

45.88%-5.92M

-119.85%-10.11M

-53.98%-12.23M

-73.52%-34.13M

-128.10%-10.64M

Net income from continuing operations

-5.17%-10.48M

-15.94%-13.08M

-37.64%-10.79M

-8.33%-42.49M

-15.71%-13.42M

16.79%-9.96M

-32.78%-11.28M

-9.42%-7.84M

52.27%-39.23M

10.68%-11.59M

Operating gains losses

----

-66.67%-70K

--0

Depreciation and amortization

-0.21%465K

-1.89%466K

-3.74%463K

-0.74%1.89M

-3.31%468K

-4.31%466K

-4.62%475K

10.57%481K

17.24%1.9M

22.22%484K

Change In working capital

-208.04%-2.96M

376.29%462K

6.42%-5.19M

-130.25%-2.91M

-454.55%-195K

720.63%2.74M

-94.93%97K

-98.89%-5.55M

-120.22%-1.26M

-99.18%55K

-Change in prepaid assets

-56.55%1.58M

-359.57%-4.96M

-274.40%-936K

220.94%6.76M

123.45%1.46M

532.87%3.64M

38.85%1.91M

80.96%-250K

-1,147.00%-5.59M

-1,422.72%-6.23M

-Change in payables and accrued expense

-655.91%-4.54M

479.04%5.75M

21.36%-3.94M

-255.95%-8.47M

-120.49%-1.35M

18.78%-601K

-287.98%-1.52M

-314.93%-5M

-20.40%5.43M

-0.29%6.57M

-Change in other current liabilities

101.66%5K

-9.06%-325K

-9.22%-320K

-9.07%-1.2M

-9.15%-310K

-9.06%-301K

-9.56%-298K

-8.52%-293K

0.81%-1.1M

21.98%-284K

Cash from discontinued investing activities

Operating cash flow

-86.61%-11.05M

-6.34%-10.75M

-13.57%-13.89M

-19.03%-40.62M

-16.10%-12.35M

45.88%-5.92M

-119.85%-10.11M

-53.98%-12.23M

-73.52%-34.13M

-128.10%-10.64M

Investing cash flow

Cash flow from continuing investing activities

70.20%29.02M

1,071.96%6.48M

-196.02%-4.1M

117.83%26.97M

113.54%6.31M

1,344.83%17.05M

99.37%-667K

2,311.92%4.27M

-8,442.37%-151.2M

-5,911.08%-46.65M

Net PPE purchase and sale

-340.00%-44K

----

16.67%-30K

83.33%-9K

62.96%-10K

----

97.52%-36K

93.04%-54K

Net investment purchase and sale

70.36%29.06M

1,088.26%6.48M

-196.02%-4.1M

117.86%27M

113.57%6.32M

1,313.34%17.06M

99.38%-656K

--4.27M

---151.16M

---46.59M

Cash from discontinued investing activities

Investing cash flow

70.20%29.02M

1,071.96%6.48M

-196.02%-4.1M

117.83%26.97M

113.54%6.31M

1,344.83%17.05M

99.37%-667K

2,311.92%4.27M

-8,442.37%-151.2M

-5,911.08%-46.65M

Financing cash flow

Cash flow from continuing financing activities

-109.52%-2K

-99.97%1K

42,419.51%17.43M

-96.13%2.94M

-100.21%-158K

320.00%21K

3.03M

41K

-36.13%75.76M

-39.03%75.75M

Net common stock issuance

--0

--18.11M

-95.90%3.13M

--0

--3.13M

--0

-40.56%76.24M

Proceeds from stock option exercised by employees

--0

313.33%62K

--0

320.00%21K

--0

--41K

--15K

--10K

Net other financing activities

---2K

--1K

---680K

48.89%-253K

---158K

--0

----

-76.16%-495K

----

Cash from discontinued financing activities

Financing cash flow

-109.52%-2K

-99.97%1K

42,419.51%17.43M

-96.13%2.94M

-100.21%-158K

320.00%21K

--3.03M

--41K

-36.13%75.76M

-39.03%75.75M

Net cash flow

Beginning cash position

0.65%19.4M

-12.41%23.67M

-30.67%24.23M

-75.82%34.95M

84.61%30.43M

-26.53%19.28M

-80.18%27.03M

-75.82%34.95M

205.27%144.51M

-35.92%16.48M

Current changes in cash

61.15%17.97M

44.90%-4.27M

93.00%-554K

90.22%-10.72M

-133.57%-6.2M

214.26%11.15M

92.96%-7.75M

2.66%-7.92M

-212.75%-109.57M

-84.46%18.47M

End cash Position

22.82%37.37M

0.65%19.4M

-12.41%23.67M

-30.67%24.23M

84.61%30.43M

-26.53%19.28M

-80.18%27.03M

-75.82%34.95M

Free cash flow

-87.04%-11.1M

-6.22%-10.75M

-13.57%-13.89M

-18.38%-40.65M

-15.60%-12.36M

45.92%-5.93M

-123.14%-10.12M

-50.31%-12.23M

-61.71%-34.34M

-96.53%-10.7M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-86.61%-11.05M	-6.34%-10.75M	-13.57%-13.89M	-19.03%-40.62M	-16.10%-12.35M	45.88%-5.92M	-119.85%-10.11M	-53.98%-12.23M	-73.52%-34.13M	-128.10%-10.64M
Net income from continuing operations	-5.17%-10.48M	-15.94%-13.08M	-37.64%-10.79M	-8.33%-42.49M	-15.71%-13.42M	16.79%-9.96M	-32.78%-11.28M	-9.42%-7.84M	52.27%-39.23M	10.68%-11.59M
Operating gains losses	----	----	----	----	----	----	----	----	-66.67%-70K	--0
Depreciation and amortization	-0.21%465K	-1.89%466K	-3.74%463K	-0.74%1.89M	-3.31%468K	-4.31%466K	-4.62%475K	10.57%481K	17.24%1.9M	22.22%484K
Change In working capital	-208.04%-2.96M	376.29%462K	6.42%-5.19M	-130.25%-2.91M	-454.55%-195K	720.63%2.74M	-94.93%97K	-98.89%-5.55M	-120.22%-1.26M	-99.18%55K
-Change in prepaid assets	-56.55%1.58M	-359.57%-4.96M	-274.40%-936K	220.94%6.76M	123.45%1.46M	532.87%3.64M	38.85%1.91M	80.96%-250K	-1,147.00%-5.59M	-1,422.72%-6.23M
-Change in payables and accrued expense	-655.91%-4.54M	479.04%5.75M	21.36%-3.94M	-255.95%-8.47M	-120.49%-1.35M	18.78%-601K	-287.98%-1.52M	-314.93%-5M	-20.40%5.43M	-0.29%6.57M
-Change in other current liabilities	101.66%5K	-9.06%-325K	-9.22%-320K	-9.07%-1.2M	-9.15%-310K	-9.06%-301K	-9.56%-298K	-8.52%-293K	0.81%-1.1M	21.98%-284K
Cash from discontinued investing activities
Operating cash flow	-86.61%-11.05M	-6.34%-10.75M	-13.57%-13.89M	-19.03%-40.62M	-16.10%-12.35M	45.88%-5.92M	-119.85%-10.11M	-53.98%-12.23M	-73.52%-34.13M	-128.10%-10.64M
Investing cash flow
Cash flow from continuing investing activities	70.20%29.02M	1,071.96%6.48M	-196.02%-4.1M	117.83%26.97M	113.54%6.31M	1,344.83%17.05M	99.37%-667K	2,311.92%4.27M	-8,442.37%-151.2M	-5,911.08%-46.65M
Net PPE purchase and sale	-340.00%-44K	----	----	16.67%-30K	83.33%-9K	62.96%-10K	----	----	97.52%-36K	93.04%-54K
Net investment purchase and sale	70.36%29.06M	1,088.26%6.48M	-196.02%-4.1M	117.86%27M	113.57%6.32M	1,313.34%17.06M	99.38%-656K	--4.27M	---151.16M	---46.59M
Cash from discontinued investing activities
Investing cash flow	70.20%29.02M	1,071.96%6.48M	-196.02%-4.1M	117.83%26.97M	113.54%6.31M	1,344.83%17.05M	99.37%-667K	2,311.92%4.27M	-8,442.37%-151.2M	-5,911.08%-46.65M
Financing cash flow
Cash flow from continuing financing activities	-109.52%-2K	-99.97%1K	42,419.51%17.43M	-96.13%2.94M	-100.21%-158K	320.00%21K	3.03M	41K	-36.13%75.76M	-39.03%75.75M
Net common stock issuance	--0	--0	--18.11M	-95.90%3.13M	--0	--0	--3.13M	--0	-40.56%76.24M	-40.56%76.24M
Proceeds from stock option exercised by employees	--0	--0	--0	313.33%62K	--0	320.00%21K	--0	--41K	--15K	--10K
Net other financing activities	---2K	--1K	---680K	48.89%-253K	---158K	--0	----	----	-76.16%-495K	----
Cash from discontinued financing activities
Financing cash flow	-109.52%-2K	-99.97%1K	42,419.51%17.43M	-96.13%2.94M	-100.21%-158K	320.00%21K	--3.03M	--41K	-36.13%75.76M	-39.03%75.75M
Net cash flow
Beginning cash position	0.65%19.4M	-12.41%23.67M	-30.67%24.23M	-75.82%34.95M	84.61%30.43M	-26.53%19.28M	-80.18%27.03M	-75.82%34.95M	205.27%144.51M	-35.92%16.48M
Current changes in cash	61.15%17.97M	44.90%-4.27M	93.00%-554K	90.22%-10.72M	-133.57%-6.2M	214.26%11.15M	92.96%-7.75M	2.66%-7.92M	-212.75%-109.57M	-84.46%18.47M
End cash Position	22.82%37.37M	0.65%19.4M	-12.41%23.67M	-30.67%24.23M	-30.67%24.23M	84.61%30.43M	-26.53%19.28M	-80.18%27.03M	-75.82%34.95M	-75.82%34.95M
Free cash flow	-87.04%-11.1M	-6.22%-10.75M	-13.57%-13.89M	-18.38%-40.65M	-15.60%-12.36M	45.92%-5.93M	-123.14%-10.12M	-50.31%-12.23M	-61.71%-34.34M	-96.53%-10.7M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data